Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 3 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Recs

0
Player Avatar CATMANF800 (< 20) Submitted: 12/3/2011 2:51:12 PM : Outperform Start Price: $4.78 VICL Score: -44.52

Technicals

Featured Broker Partners


Advertisement